Nutcracker Therapeutics

📍 Emeryville, United States🗓 Founded 2018👥 143 employees💰 Last funded Apr 2023
Biotechnology Research🌐 nutcrackerx.com
Website LinkedIn
Nutcracker Therapeutics is an RNA therapeutics company that has combined the power of advanced engineering with high-precision biosynthesis to deploy a complete RNA therapeutics platform. Armed with this high-tech advantage, we have developed a wholly owned pipeline of RNA therapeutic programs and established partnership initiatives with top clinical investigators at several leading institutions across the globe. With our platform’s ability to accelerate the development of life-changing RNA therapeutics, we seek to advance breakthrough RNA therapies at high velocity through all stages of development across a variety of indications. Our technology platform has the potential to significantly reduce costs and cycle times for RNA therapeutic development, with dramatic advantages in capacity scaling and point-of-care delivery over other RNA manufacturing approaches.
2
Total investors
1
Early stage
1
Mid stage
0
Late stage
2018
Founded

Investors

2 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
2
Frequently asked questions
Who invested in Nutcracker Therapeutics?
Nutcracker Therapeutics has 2 investors on record on gritt.io, including 1 early-stage backers, 1 mid-stage.
When did Nutcracker Therapeutics last raise funding?
The most recent investment in Nutcracker Therapeutics recorded on gritt.io was in April 2023.
When was Nutcracker Therapeutics founded?
Nutcracker Therapeutics was founded in 2018.
What industry is Nutcracker Therapeutics in?
Nutcracker Therapeutics operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Nutcracker Therapeutics based?
Nutcracker Therapeutics is headquartered in Emeryville, United States.